Angel Invest Boston

Join Sal's Investment Syndicate List: Click to Join Repeat biotech founder Todd Zion on SmartCells (acquired by Merck for $500MM) and his current venture Akston Bio which is doing cool things with proteins. Todd has valuable insights on VC funding, angel investing and founding teams. This interview’s a peach! Intro of Todd Zion, PhD Co-Founder of SmartCells (Merck) and Akston Bio Todd Zion Was Fascinated by the Potential of Polymers to Do Powerful Things Smart Drug Delivery – Making Insulin Adapt to Blood Glucose Levels “…then got bitten by the bug, like I said, of the entrepreneurial spirit that runs quite strong through MIT.” “…with SmartCells, we made a conscious effort to build a company that could be capital efficient and achieve what angels want out of an investment…” Jeff Behrens’ Experience at Siamab Is Discussed Todd Zion Is Leery of Raising Big Money Because It Raises Costs “…you should always be betting on the jockey and not necessarily the horse.” “Sometimes you may throw out really good ideas, d